C-luminary Biotech was founded in 2018 and is headquartered in Chengdu, China, with a research and development center in Suzhou and industrial platforms in Sichuan and Hunan, is a professional enterprise engaged in the research, development, production, and sale of in vitro diagnostic products.

Recently, the internationally renowned Top Employers Institute released the "China Top Employers 2024" list.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

MHRA automatically moved the U.K.’s three existing notified bodies, BSI, SGS and UL, to the approved body scheme when the country split from the European Union. Since then, efforts to add capacity have proceeded slowly. The U.K. affiliate of DEKRA, a notified body in the EU, became the first new approved body for medical devices 11 months ago.

Recently, Wondfo Biotech received the confirmation letter of in vitro diagnostic pre-qualification (PQ) issued by the World Health Organization (WHO). Recommended purchase list.

The “COVID-19 Antigen Rapid Test – Anterior Nasal Swab” and the “COVID-19 Antigen Rapid Test (Colloidal Gold) – Saliva” developed independently by JOINSTAR Biomedical Technology Co., Ltd obtained the EU CE certification for self-testing on January 20th and February 2nd, issued by the CE 1434.

On January 4th, the four-channel iPonatic nucleic acid detection analyzer of Sansure Biotech was certified by FDA. This is another global authority certification obtained after the approval of China NMPA and the European Union CE certification.

Siemens Healthineers said Tuesday that the TüV Rheinland certification agency has certified its first products under the new European In Vitro Diagnostic Regulation.